Sign in

Medicines UK

@medicinesuk.bsky.social
84 followers 264 following 38 posts

Medicines UK (formerly the BGMA) is dedicated to ensuring a sustainable and cost-effective supply of essential generic and biosimilar medicines to UK patients.

PostsRepliesMedia
Reposted by Medicines UK
Medical Journalists' Association @mja-uk.bsky.social · 22/09/2026
And now News Story (Specialist) goes to @emahase.bsky.social for her @bmj.com article on access to Mounjaro. Huge Congratulations! @medicinesuk.bsky.social #mjaawards
012
Medicines UK @medicinesuk.bsky.social · 17/09/2026
A chance to relive our summer conference or check out what you missed if you couldn't make it. See link below. vimeo.com/1226982766?f...
vimeo.com
Medicines UK Conference 2026
This is "Medicines UK Conference 2026" by Jeremy Durrant on Vimeo, the home for high quality videos and the people who love them.
000
Medicines UK @medicinesuk.bsky.social · 09/09/2026
The role of medicines to the successful deployment of neighbourhood health will be crucial. Medicines UK convened a roundtable of ICB leaders to discuss the implementation of neighbourhood health and how greater visibility of patent expiries could help drive quicker uptake, savings and access.
100
Medicines UK @medicinesuk.bsky.social · 29/07/2026
To find out more about our new Medicines UK API Council and to join contact info@medicinesuk.com
001
Medicines UK @medicinesuk.bsky.social · 27/07/2026
ICYMI -The latest episode of the Medicines Matters podcast is available to listen and download. This episode focuses on NICE and its whole life cycle approach and what it means for the off-patent sector. Listen at the link below. #Generics #Biosimilars #NHS bgma.podbean.com/e/medicines-...
bgma.podbean.com
Medicines Matters - Episode 10 - Dr Jacoline Bouvy, the Deputy Director for Medicines Evaluation at NICE | Medicine Matters - a podcast from Medicines UK
Episode 10 - Dominic Wake, the head of corporate affairs, northern cluster at Sandoz, and a Medicines UK member speaks to Dr Jacoline Bouvy, the Deputy Director for Medicines Evaluation at NICE. They ...
000
Medicines UK @medicinesuk.bsky.social · 22/07/2026
It was only just over a week ago we held our second annual Medicines UK conference. It was a fantastic day and we have received brilliant feedback from delegates. We had a stellar line-up of speakers including medicines minister Preet Gill and work is already underway on the next event.
000
Medicines UK @medicinesuk.bsky.social · 21/07/2026
In our latest podcast episode, Dominic Wake, the head of corporate affairs, northern cluster at Sandoz, and a Medicines UK member speaks to Jacoline Bouvy, the Deputy Director for Medicines Evaluation at the National Institute for Health and Care Excellence. www.podbean.com/eas/pb-tn2je...
001
Reposted by Medicines UK
Medical Journalists' Association @mja-uk.bsky.social · 26/05/2026
We are delighted to announce @medicinesuk.bsky.social as a sponsor for the 2026 #MJAAwards. Medicines UK is the trade body representing manufacturers of 85% of the prescription drugs used by the NHS. You can find out more here: mjauk.org/about/sponso... Awards entries close June 10...
mjauk.org
Medicines UK - Medical Journalists’ Association
The Medical Journalists’ Association is pleased to welcome Medicines UK as a new sponsor for the 2026 MJA Awards, supporting the News Story (Specialist Audience) category. About Medicines UK Medicines...
001
Medicines UK @medicinesuk.bsky.social · 21/05/2026
This week we announced the election of a new Chair of Medicines UK, with Paul Burden of Accord Healthcare taking on the role from Diane DiGangi Trench of Sandoz. Read the press release on Paul's appointment medicinesuk.com/news/paul-bu... #Generics #biosimilars #NHS
medicinesuk.com
Paul Burden takes chair role at Medicines UK
Medicines UK has announced that Paul Burden will become its new chair. Paul, who is the UK Country Head for Accord Healthcare, will succeed Diane Di Gangi-Trench, Head of Northern Cluster Europe, Sand...
000
Medicines UK @medicinesuk.bsky.social · 20/05/2026
The latest episode of the Medicines Matters podcast brought to you by Medicines UK is now live and available to download. To listen to the episode click on the link below. mcdn.podbean.com/mf/web/pascd...
000
Medicines UK @medicinesuk.bsky.social · 18/05/2026
000
Medicines UK @medicinesuk.bsky.social · 29/04/2026
Our chief executive Mark Samuels spoke to Evan Davis on Radio 4's PM programme about how medicines supplies to the UK are being impacted by the Middle East conflict. Listen from 26 minutes on the link below. #Generics #Biosimilars #NHS www.bbc.co.uk/sounds/play/...
bbc.co.uk
PM - President Trump hails ‘most cherished friendship' - BBC Sounds
Royals welcomed at the White House as a leaked video of the UK ambassador emerges.
000
Medicines UK @medicinesuk.bsky.social · 24/03/2026
The latest episode of the Medicine Matters podcast is now available to listen and download using the link below. The focus for this discussion is medicines reclassification and how it is benefiting patients and manufacturers. www.podbean.com/eas/pb-b84rn...
000
Medicines UK @medicinesuk.bsky.social · 05/02/2026
We have launched a new website for the association full of content and information about the generic, biosimilar and value-added medicines sector. Our members fulfil 85% of all NHS patient prescriptions and are integral to the safe and sustainable running of the UK's health systems. medicinesuk.com
medicinesuk.com
Home
Medicines UK is the trading name of the British Generic Manufacturers Association, which represents the suppliers of 85% of NHS prescription medicines, annually delivering over £20bn in annual healthc...
000
Medicines UK @medicinesuk.bsky.social · 02/02/2026
The latest episode of the Medicine Matters podcast is now available to listen and watch. Many thanks to Charles Joynson, founder of WaveData Ltd for his insight and expertise on pricing in the UK market. Please click on the link below. #generics #biosimilars #NHS bgma.podbean.com/e/medicine-m...
010
Medicines UK @medicinesuk.bsky.social · 10/12/2025
We were delighted to welcome @mhragovuk.bsky.social chief executive Lawrence Tallon to our Medicines UK members meeting today. Great discussion and engagement across a wide range of issues impacting the licencing and supply of generic and biosimilar medicines. #generics #biosimilars #MHRA
000
Medicines UK @medicinesuk.bsky.social · 01/12/2025
Medicines UK chief executive Mark Samuels comments on the announcement today of the deal between the UK and US on pharmaceutical tariffs. Read the full statement below. #generics #biosimilars
010
Medicines UK @medicinesuk.bsky.social · 27/11/2025
Listen to the latest episode of the Medicine Matters podcast featuring Adele Paterson, chief executive of International Health Partners. She talks about the vital role of the NGO in distributing essential medicines to where they are needed most. bgma.podbean.com/e/medicine-m... #generics
010
Medicines UK @medicinesuk.bsky.social · 24/11/2025
It was great to see our association leading a panel discussion at the CPC North event in Manchester at the end of last week on the topic of medicine shortages. #generics #biosimilars #NHS
010
Medicines UK @medicinesuk.bsky.social · 21/11/2025
Next week, Medicines UK, alongside NHS England and the MHRA will be hosting a free one hour virtual webinar on streamlining the regulatory pathway for biosimilars in the UK. Full details below and how to reserve a place. #biosimilars #NHS #mhra
000
Medicines UK @medicinesuk.bsky.social · 21/11/2025
Great discussions and insight shared at yesterday’s roundtable featuring medicines minister Dr Zubir Ahmed MP, who met with global leaders from some of the world’s leading off-patent companies. In the UK, generics and biosimilars fulfil 85% of NHS patient prescriptions. #generics #biosimilars #NHS
000
Medicines UK @medicinesuk.bsky.social · 17/11/2025
The Chancellor will next week unveil her Autumn Statement to the nation. We have been examining the policy areas which can support our industry - which supplies 85% of the NHS' medicines - and help boost the broader UK economy. You can read our full submission at medicinesuk.com/view-news/20...
000
Medicines UK @medicinesuk.bsky.social · 12/11/2025
Our chief executive Mark Samuels today gave evidence to the House of Lords public services committee inquiry into medicines security. parliamentlive.tv/event/index/...
010
Medicines UK @medicinesuk.bsky.social · 30/10/2025
Our reaction to the news that the National Institute for Health and Care Excellence (NICE) has recommended generic abiraterone for prostate cancer which will benefit thousands of patients by increasing access and saving the NHS millions of pounds.
010
Medicines UK @medicinesuk.bsky.social · 22/10/2025
Our chief executive Mark Samuels writes in the The Economic Times on the areas where further collaboration could occur between India and the UK in developing their free-trade agreement and why off-patent medicines are a natural place to start. pharma.economictimes.indiatimes.com/news/pharma-...
pharma.economictimes.indiatimes.com
A Wise Prescription for UK–India Growth: Life Sciences Must Lead the Way
UK-India Growth: Explore how the UK and India can collaborate in the field of life sciences to drive economic growth and enhance healthcare access. Learn about the potential of off-patent medicines an...
010
Medicines UK @medicinesuk.bsky.social · 23/09/2025
Another episode has dropped of the Medicine Matters podcast from Medicines UK. View here podbean.com/eas/pb-kgyh9...
010
Medicines UK @medicinesuk.bsky.social · 17/09/2025
The latest episode of the Medicine Matters podcast is available to listen and download below. In this edition we discuss data and what patent expiries mean for NHS savings and increased patient access. www.podbean.com/ew/pb-e759x-... #generics #biologics #medicines
010
Medicines UK @medicinesuk.bsky.social · 14/08/2025
Creating a world class life sciences sector requires an ambitious, high performing regulator. Our chief executive Mark Samuels pens his thoughts on this critical topic for the think tank @ukandeu.bsky.social Read the full article below. ukandeu.ac.uk/making-briti...
ukandeu.ac.uk
Making British life sciences regulation competitive - UK in a changing Europe
Mark Samuels considers medicines regulation in the UK and argues there needs to be a clearer vision from regulators to ensure the UK remains competitive.
020
Medicines UK @medicinesuk.bsky.social · 11/08/2025
Our reaction below to the Department for Health Social Care and NHS England’s ongoing work and future plans to improve shortage management and strengthen medicines supply chain resilience. You can read the full report at www.gov.uk/government/p... #generics #biosimilars
030
Medicines UK @medicinesuk.bsky.social · 08/08/2025
Our latest monthly analysis of medicine supply issues has been published on our website. It shows that overall there is currently a decline in the total number of shortages. Figures are at at their lowest level for nearly three years. www.medicinesuk.com/view-news/bg... #generics #biosimilars
medicinesuk.com
Medicines UK - View news
000
Medicines UK @medicinesuk.bsky.social · 04/08/2025
What does President Trump's letter to 17 pharmaceutical companies on most favoured nation pricing mean for the cost of medicines in the UK? Our chief executive Mark Samuels spoke to the BBC about this topic on BBC Radio 4. Listen to the link below from 32 mins. www.bbc.co.uk/sounds/play/...
bbc.co.uk
The World Tonight - Trump moves nuclear submarines after Russian ex-president's comments - BBC Sounds
Donald Trump ordered two nuclear submarines to "be positioned in the appropriate regions"
010
Medicines UK @medicinesuk.bsky.social · 31/07/2025
Only a few short weeks ago, Medicines UK held its first ever conference and we were delighted to welcome Minister of State at the Department of Health and Social Care Karin Smyth as the keynote speaker. If you missed the event, see below for a taster. vimeo.com/1105497497/1...
vimeo.com
Medicines UK Conference
This is "Medicines UK Conference" by Jeremy Durrant on Vimeo, the home for high quality videos and the people who love them.
010
Medicines UK @medicinesuk.bsky.social · 25/07/2025
Our chief executive Mark Samuels was on the BBC's World Business Report this week discussing the impact of trade and tariffs. Listen to the interview on the link below. www.bbc.co.uk/sounds/play/...
bbc.co.uk
World Business Report - AstraZeneca announces $50 billion investment in the United States - BBC Sounds
The pharmaceutical giant invests in US ahead of potential tariffs
000
Medicines UK @medicinesuk.bsky.social · 16/07/2025
The Government's life sciences strategy is out today and we are delighted the recognition in there of the importance of the off-patent sector. See below the reaction from Medicines UK's chief executive Mark Samuels. #generics #biosimilars
000
Medicines UK @medicinesuk.bsky.social · 11/07/2025
It's been a momentous week at Medicines UK with our inaugural conference. We welcomed health minister Karin Smyth MP who spoke about the importance of our sector to the NHS and outlined plans to make the UK the premier global location for biosimilar launches.
000
Medicines UK @medicinesuk.bsky.social · 09/07/2025
A brilliant day of insight, collaboration and partnership at the Medicines UK conference. The off-patent industry - which is responsible for supplying four out of five NHS medicines - came together to discuss the topics which matter most with colleagues across the supply chain and Government.
000
Medicines UK @medicinesuk.bsky.social · 09/05/2025
In an uncertain world, we must prioritise the resilience and security of medicines supply. Read the comments of our chief executive Mark Samuels in inews: inews.co.uk/news/health/...
inews.co.uk
'An act of war': How China's stranglehold on antibiotics could imperil the UK
With China now controlling some 80 per cent of the key chemicals used to make the world’s supply of vital medicines, there are calls for Britain to rethink its supply chains
000
Medicines UK @medicinesuk.bsky.social · 01/05/2025
The BGMA is now Medicines UK. Our new name reflects the scale of the contributions our members make to the overall medicines dispensed by the NHS. Our new brand reinvigorates our mission to create a sustainable and cost-effective supply of generic and biosimilar medicines to UK patients.
000
Medicines UK @medicinesuk.bsky.social · 29/04/2025
We are proudly launching our new name and brand as our association becomes Medicines UK. Our members supply the vast majority of prescription packs the NHS relies on. Watch this short film from our chief executive Mark Samuels on why we have adopted a new name. Find out more: www.medicinesuk.com
000